Characterization of novel Bruton's tyrosine kinase gene mutations in Central European patients with agammaglobulinemia
Authors:
- Rosa Maria AspalterRARosa Maria Aspalter
- Martha Marianne EiblMEMartha Marianne Eibl
- Hermann Maximilian WolfHWHermann Maximilian Wolf
- 1 March 2007
- journal article
- Published by Elsevier in Molecular Immunology
- Vol. 44 (7) , 1639-1643
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- A genotype-phenotype correlation study in a group of 54 patients with X-linked agammaglobulinemiaJournal of Allergy and Clinical Immunology, 2005
- Nonsense-mediated mRNA decay: molecular insights and mechanistic variations across speciesCurrent Opinion in Cell Biology, 2005
- Genetic analysis of patients with defects in early B‐cell developmentImmunological Reviews, 2005
- Clinical and mutational characteristics of X-linked agammaglobulinemia and its carrier identified by flow cytometric assessment combined with genetic analysisJournal of Allergy and Clinical Immunology, 2001
- Alu Repeats and Human DiseaseMolecular Genetics and Metabolism, 1999
- Unusual Mutations in Btk: An Insertion, a Duplication, an Inversion, and Four Large DeletionsClinical Immunology, 1999
- Mutations in Btk in Patients with Presumed X-Linked AgammaglobulinemiaThe American Journal of Human Genetics, 1998
- Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLAClinical and Experimental Immunology, 1998
- Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemiaCell, 1993
- Partial gene duplication as a cause of human diseaseHuman Mutation, 1992